AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit Before Tax | ₹5,066 Cr | ₹4,380 Cr | ₹2,613 Cr | ₹3,373 Cr | ₹7,344 Cr |
What is the latest Profit Before Tax of AUROBINDO PHARMA ?
Year | Profit Before Tax |
---|---|
Mar2025 | ₹5,066 Cr |
Mar2024 | ₹4,380 Cr |
Mar2023 | ₹2,613 Cr |
Mar2022 | ₹3,373 Cr |
Mar2021 | ₹7,344 Cr |
How is Profit Before Tax of AUROBINDO PHARMA Trending?
Years | Profit Before Tax | % Change | |
---|---|---|---|
Mar2025 | ₹5,066 Cr | 15.67 | |
Mar2024 | ₹4,380 Cr | 67.66 | |
Mar2023 | ₹2,613 Cr | -22.54 | |
Mar2022 | ₹3,373 Cr | -54.07 | |
Mar2021 | ₹7,344 Cr | - |
Compare Profit Before Tax of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹64,953.8 Cr | 1.8% | 6.9% | -27.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.8% |
6.9% |
-27.3% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses